Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 33 results.
User Information
Export Records
  1. 1.   Stable and Potent Selenomab-Drug Conjugates
  2. Li, Xiuling; Nelson, Christopher; Nair, Rajesh R; Hazlehurst, Lori; Moroni, Tina; Martinez-Acedo, Pablo; Nanna, Alex R; Hymel, David; Burke, Terrence; Rader, Christoph
  3. Cell Chemical Biology. 2017, Apr 20; 24(4): 433-442.
  1. 2.   Cre-mediated recombination can induce apoptosis in vivo by activating the p53 DNA damage-induced pathway
  2. Zhu, J. J.; Nguyen, M. T.; Nakamura, E.; Yang, J. M.; Mackem, S.
  3. Genesis. 2012, Feb; 50(2): 102-111.
  1. 3.   Osteoblast Precursors, but Not Mature Osteoblasts, Move into Developing and Fractured Bones along with Invading Blood Vessels
  2. Maes, C.; Kobayashi, T.; Selig, M. K.; Torrekens, S.; Roth, S. I.; Mackem, S.; Carmeliet, G.; Kronenberg, H. M.
  3. Developmental Cell. 2010, Aug; 19(2): 329-344.
  1. 4.   NCAD, a Database Integrating the Intrinsic Conformational Preferences of Non-Coded Amino Acids
  2. Revilla-Lopez, G.; Torras, J.; Curco, D.; Casanovas, J.; Calaza, M. I.; Zanuy, D.; Jimenez, A. I.; Cativiela, C.; Nussinov, R.; Grodzinski, P.; Aleman, C.
  3. Journal of Physical Chemistry B. 2010, Jun; 114(21): 7413-7422.
  1. 5.   Human Type 1 and 17 Responses in Latent Tuberculosis Are Modulated by Coincident Filarial Infection through Cytotoxic T Lymphocyte Antigen-4 and Programmed Death-1
  2. Babu, S.; Bhat, S. Q.; Kumar, N. P.; Jayantasri, S.; Rukmani, S.; Kumaran, P.; Gopi, P. G.; Kolappan, C.; Kumaraswami, V.; Nutman, T. B.
  3. Journal of Infectious Diseases. 2009 200(2): 288-298.
  1. 6.   Novel method for in vitro O-glycosylation of proteins: Application for bioconjugation
  2. Ramakrishnan, B.; Boeggeman, E.; Qasba, P. K.
  3. Bioconjugate Chemistry. 2007, Nov-Dec; 18(6): 1912-1918.
  1. 7.   Enhanced soluble protein expression using two new fusion tags
  2. Chatterjee, D. K.; Esposito, D.
  3. Protein Expression and Purification. 2006, MAR; 46(1): 122-129.
  1. 8.   Comparative analysis of tandem T7-like promoter containing regions in enterobacterial genomes reveals a novel group of genetic islands
  2. Chen, Z. H.; Schneider, T. D.
  3. Nucleic Acids Research. 2006 34(4): 1133-1147.
  1. 9.   A mechanism of palindromic gene amplification in Saccharomyces cerevisiae
  2. Rattray, A. J.; Shafer, B. K.; Neelam, B.; Strathern, J. N.
  3. Genes & Development. 2005, JUN 1; 19(11): 1390-1399.
  1. 10.   Switches in bacteriophage lambda development
  2. Oppenheim, A. B.; Kobiler, O.; Stavans, J.; Court, D. L.; Adhya, S.
  3. Annual Review of Genetics. 2005 39: 409-429.
  1. 11.   Gateway cloning is compatible with protein secretion from Pichia pastoris
  2. Esposito, D.; Gillette, W. K.; Miller, D. A.; Taylor, T. E.; Frank, P. H.; Hu, R. Q.; Bekisz, J.; Hernandez, J.; Cregg, J. M.; Zoon, K. C.; Hartley, J. L.
  3. Protein Expression and Purification. 2005 40(2): 424-428.
  1. 12.   Effect of structure and sequence on mutations induced by site-specific polycyclic aromatic hydrocarbon diol epoxide-DNA adducts
  2. Ponten, I.
  3. Mutagenesis. 2004, NOV; 19(6): 499, Abstract 3-500, Abstract 3.
  1. 13.   Efficient site-specific processing of fusion proteins by tobacco vein mottling virus protease in vivo and in vitro
  2. Nallamsetty, S.; Kapust, R. B.; Tozser, J.; Cherry, S.; Tropea, J. E.; Copeland, T. D.; Waugh, D. S.
  3. Protein Expression and Purification. 2004, NOV; 38(1): 108-115.
  1. 14.   ORFeome cloning and systems biology: Standardized mass production of the parts from the parts-list
  2. Brasch, M. A.; Hartley, J. L.; Vidal, M.
  3. Genome Research. 2004, OCT; 14(10B): 2001-2009.
  1. 15.   Human ORFeome version 1.1: A platform for reverse proteomics
  2. Rual, J. F.; Hirozane-Kishikawa, T.; Hao, T.; Bertin, N.; Li, S. M.; Dricot, A.; Li, N.; Rosenberg, J.; Lamesch, P.; Vidalain, P. O.; Clingingsmith, T. R.; Hartley, J. L.; Esposito, D.; Cheo, D.; Moore, T.; Simmons, B.; Sequerra, R.; Bosak, S.; Doucette-Stamm, L.; Le Peuch, C.; Vandenhaute, J.; Cusick, M. E.; Albala, J. S.; Hill, D. E.; Vidal, M.
  3. Genome Research. 2004, OCT; 14(10B): 2128-2135.
  1. 16.   Highly restricted expression cerebellar Purkinje cells
  2. Zhang, X. M.; Ng, A. H. L.; Tanner, J. A.; Wu, W. T.; Copeland, N. G.; Jenkins, N. A.; Huang, J. D.
  3. Genesis. 2004, SEP; 40(1): 45-51.
  1. 17.   Brain-specific deletion of neuropathy target esterase/swisscheese results in neurodegeneration
  2. Akassoglou, K.; Malester, B.; Xu, J. X.; Tessarollo, L.; Rosenbluth, J.; Chao, M. V.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(14): 5075-5080.
  1. 18.   Proteome analysis of posttranslational modifications
  2. Veenstra, T. D.
  3. Proteome Characterization and Proteomics. 2003; 65 : 161-194.
  1. 19.   Structures of two highly homologous bacterial L-asparaginases: a case of enantiomorphic space groups
  2. Jaskolski, M.; Kozak, M.; Lubkowski, J.; Palm, G.; Wlodawer, A.
  3. Acta Crystallographica Section D-Biological Crystallography. 2001 57(Pt. 3): 369-377.
  1. 20.   Differences between the mutational consequences of replication of cis- and trans-opened benzo[a]pyrene 7,8-diol 9,10-epoxide- deoxyguanosine adducts in M13mp7L2 constructs
  2. Ponten, I.; Kroth, H.; Sayer, J. M.; Dipple, A.; Jerina, D. M.
  3. Chemical Research in Toxicology. 2001 14(6): 720-726.
  1. 21.   Conditional control of gene expression in the mouse
  2. Lewandoski, M.
  3. Nature Reviews Genetics. 2001 2(10): 743-755.
  1. 22.   Factors determining mutagenic potential for individual cis and trans opened benzo[c]phenanthrene diol epoxide-deoxyadenosine adducts
  2. Ponten, I.; Sayer, J. M.; Pilcher, A. S.; Yagi, H.; Kumar, S.; Jerina, D. M.; Dipple, A.
  3. Biochemistry. 2000 39(14): 4136-4144.
  1. 23.   Mutational spectra for polycyclic aromatic hydrocarbons in the supF target gene
  2. Bigger, C. A. H.; Ponten, I.; Page, J. E.; Dipple, A.
  3. Mutation Research - Fundamental & Molecular Mechanisms of Mutagenesis. 2000 450(1-2 Special Issue SI): 75-93.
  1. 24.   Mutational consequences of replication of M13mp7L2 constructs containing cis-opened benzo
  2. Page, J. E.; Pilcher, A. S.; Yagi, H.; Sayer, J. M.; Jerina, D. M.; Dipple, A.
  3. Chemical Research in Toxicology. 1999 12(3): 258-263.
  1. 25.   Site-specific mutagenesis with benzo
  2. Page, J. E.; Liang, C. Y.; Sayer, J. M.; Jerina, D. M.; Dipple, A.
  3. Polycyclic Aromatic Compounds. 1999 16(1-4): 99-108.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel